GLOBAL NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

GLOBAL NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

The global neurostimulation device market is anticipated to grow to $XX million by 2027, at a CAGR of 10.01% between 2019 and 2027. Neurostimulation is a potential alternative for individuals unresponsive to drug therapy or surgeries. Neurostimulation devices help in the therapeutic activation of the nervous system.

GLOBAL NEUROSTIMULATION DEVICE  MARKET FORECAST 2019-2027

Global Neurostimulation Device Market by System (Spinal Cord Stimulators (Scs), Deep Brain Stimulators (Dbs), Sacral Nerve Stimulators (Sns), Vagus Nerve Stimulators (Vns), Gastric Electric Stimulator, Other System)  by Applications (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Other Applications) by Geography.

Request free sample

The global neurostimulation device market is anticipated to grow to $XX million by 2027, at a CAGR of 10.01% between 2019 and 2027. Neurostimulation is a potential alternative for individuals unresponsive to drug therapy or surgeries. Neurostimulation devices help in the therapeutic activation of the nervous system. The following factors primarily drive the neurostimulation devices market:

  • The high occurrence of neuro diseases
  • Developments in technology
  • Rising demand for minimally invasive surgeries
  • The high market potential for SCS devices in neurostimulation
  • Increasing geriatric population
  • Favorable reimbursement and insurance approval policies

Neurostimulation Device Market

To know more about this report, request a free sample copy.

The important drivers increasing growth in the global neurostimulation device market are the high occurrence of diseases and increasing geriatric population. Changing lifestyles, social pressure and stressful life events can lead to a range of disorders, including mood swings and anxiety. Aging is considered as the greatest risk factor for the development of diseases such as Parkinson’s and Alzheimer’s diseases and therefore, the fact that the global base of geriatric population is expected to grow over the next six years is expected to serve this market as a high impact rendering driver.

The applications of neurostimulation device market are used extensively for various purposes. Neurostimulation is a pain management therapy proven to be effective for many chronic pain sufferers. Neurostimulation helps mask pain by hindering pain indications before they reach the brain. It is often used to manage chronic pain in the back, arms or legs. Epilepsy is a disorder in which individuals have epileptic spasms (also known as seizures). Essential tremor (ET) is a disorder associated with the nervous system & is considered by irrepressible shaking, or “tremors,” in diverse parts and on diverse sides of the body. Fecal incontinence and Urinary (FI, UI) are co-melancholic conditions distressing over 50% of nursing domestic inhabitants. Depression is the utmost predominant incapacitating mental illness; it is considered as a syndrome of cognitive function, mood and near vegetative function. Dystonia is a medicinal term for a variety of crusade syndromes that cause contractions and muscle spasms. Gastroparesis, also called deferred gastric emptying, is a malady that slows or stops the crusade of food from the stomach to the small intestine. Parkinson’s disease (PD) is a neurodegenerative brain disorder that progresses slowly.

The safety concern and obtainability of alternative therapy are the major challenges in the neurostimulation market. Individuals face the risk of contracting infections during the implantation of the device. In addition, people may be unaware of device malfunction and may not take adequate therapy when necessary. Drugs are an alternative treatment option to neurostimulation devices. Though these devices are more effective and safer than drugs, they are still less preferred.

The global neurostimulation device market segments include applications and systems.

Applications are sub-segmented into:

  • Pain management market
  • Epilepsy market
  • Essential tremor market
  • Urinary and fecal incontinence market
  • Depression market
  • Dystonia market
  • Gastroparesis market
  • Parkinson’s disease market
  • Other applications

Systems are sub-segmented into:

  • Spinal Cord Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Gastric Electric Stimulator
  • Deep Brain Stimulators
  • Other System

This report covers the present market conditions and the growth prospects of the global neurostimulation device market for 2019-2027 and considered the revenue generated through the sales of neurostimulation device for the system as well as applications to calculate the market size by considering 2018 as the base year.

The neurostimulation device market in North America is expected to hold the largest share by 2027 possibilities of advances in technology and the availability of reimbursement by Medicare propel market growth in the country. Surgeons and major hospitals in the country are more adaptable to reforms in the healthcare industry. All these factors along with the US government’s increased focus on improving patient safety and procedure efficiency by using neurostimulation devices propel market growth. The market is expected to sustain its growth rate in the future, which will attract investors from across the world to invest in the market in the region.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the neurostimulation device market and also is anticipated to witness significant growth. The market in certain countries, such as Japan and China, is expected to grow rapidly during the forecast period because of the large patient base, which offers immense growth opportunities for vendors to increase their market share. Increased investments and improvements in healthcare infrastructure also contribute to market growth in these countries.

The neurostimulation device market is segmented based on systems which are sub-divided into deep brain stimulators, gastric electric stimulator, spinal cord stimulators, sacral nerve stimulators, vagus nerve stimulators and other system. A spinal cord stimulators system is used when systemic pain and conventional therapies provide inadequate pain relief and cause intolerable side effects. A deep brain stimulators, also known as a brain pacemaker, sends an electrical signal to the brain with the help of an implanted electrode to treat movement and affective disorders. The sacral nerve stimulators is a small stimulation device that helps to stimulate the sacral muscles by delivering mild electrical pulses. The vagus nerve stimulators involves the implantation of leads around the vagal nerve (tenth cranial nerve in the neck). Tran’s cranial peripheral nerve stimulation, magnetic stimulation, lower esophageal sphincter stimulation, diaphragm pacing, gastric electrical stimulation and cortical stimulation systems are other examples of neurostimulation devices.

The major market players of the global Neurostimulation device market are:

  • Boston Scientific Corporation
  • St. Jude Medical, Inc.
  • Cyberonics Inc.
  • Aleva Neurotherapeutics SA
  • Medtronic PLC

Boston Scientific is a global developer, manufacturer and marketer of high-quality medical devices used in the treatment of a wide range of medical conditions. Cyberonics designs develop and market implantable medical devices to hospitals and ambulatory surgery centers. Medtronic Inc. manufactures and sells device-centered medicinal treatments global. It also assembles and vends intra-operative imaging systems and image-guided surgery and offers web-based therapy management software solutions.

Key Findings of the global neurostimulation device market:

  • Spinal cord stimulators hold the largest market share in terms of a neurostimulation system
  • Pain management is the majorly used neurostimulation application
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • SPINAL CORD STIMULATORS HOLDS THE LARGEST MARKET SHARE IN TERMS OF NEUROSTIMULATION SYSTEM
      • PAIN MANAGEMENT IS THE MAJORLY USED NEUROSTIMULATION APPLICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • HIGH OCCURRENCE OF NEURO DISEASES
      • DEVELOPMENTS IN TECHNOLOGY
      • RISING DEMAND FOR MINIMALLY INVASIVE SURGERIES
      • HIGH MARKET POTENTIAL FOR SCS DEVICES IN NEUROSTIMULATION
      • INCREASING GERIATRIC POPULATION
      • FAVORABLE REIMBURSEMENT AND INSURANCE APPROVAL POLICIES
    • MARKET RESTRAINTS
      • HIGH PRICE OF NEUROMODULATION TREATMENT
      • SIDE EFFECTS OF ASSOCIATED NEUROSTIMULATION DEVICES
      • ANONYMOUS APPLIANCE OF SCS THERAPY
      • STRINGENT REGULATORY APPROVALS
    • MARKET OPPORTUNITIES
      • DEVELOPMENT OF INDICATION FOR SCS
      • INCREASING THE DEMAND FOR NEUROSTIMULATION DEVICES WITHSTANDING MRI SCANS
      • GROWING OCCURRENCE OF CHRONIC DISCOMFORT
    • MARKET CHALLENGES
      • OBTAINABILITY OF ALTERNATIVE THERAPY
      • SAFETY CONCERNS
  1. MARKET BY SYSTEM
    • SPINAL CORD STIMULATORS (SCS)
    • DEEP BRAIN STIMULATORS (DBS)
    • SACRAL NERVE STIMULATORS (SNS)
    • VAGUS NERVE STIMULATORS (VNS)
    • GASTRIC ELECTRIC STIMULATOR
    • OTHER SYSTEM
  2. MARKET BY APPLICATIONS
    • PAIN MANAGEMENT
    • EPILEPSY
    • ESSENTIAL TREMOR
    • URINARY AND FECAL INCONTINENCE
    • DEPRESSION
    • DYSTONIA
    • GASTROPARESIS
    • PARKINSON’S DISEASE
    • OTHER APPLICATIONS
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF RIVALRY
    • ESTIMATION ANALYSIS
      • INCREASING PREVALENCE OF MENTAL HEALTH PROBLEMS
      • RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE
      • RISING GERIATRIC POPULATION
    • VALUE CHAIN ANALYSIS
    • PESTLE ANALYSIS
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ALEVA NEUROTHERAPEUTICS SA
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BOSTON SCIENTIFIC CORPORATION
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • COGENTIX MEDICAL INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CYBERONICS INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • DEPUY SYNTHES COMPANIES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • LANGER MEDICAL GMBH
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ECTRON LIMITED
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • EKSO BIONICS HOLDING INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • HELIUS MEDICAL TECHNOLOGIES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • HOCOMA AG
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • MEDTRONIC PLC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NEURONETICS INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NEVRO
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • JUDE MEDICAL INC. (ACQUIRED BY ABBOTT LABORATORIES)
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • THE MAGSTIM COMPANY LIMITED
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES

 

TABLE LIST

TABLE 1        GLOBAL NEUROSTIMULATION DEVICE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        GLOBAL NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE 3        GLOBAL SPINAL CORD STIMULATORS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL DEEP BRAIN STIMULATORS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5        GLOBAL SACRAL NERVE STIMULATORS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 6        GLOBAL VAGUS NERVE STIMULATORS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 7        GLOBAL GASTRIC ELECTRIC STIMULATOR MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8        GLOBAL OTHER SYSTEM MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 9        GLOBAL NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 10      GLOBAL PAIN MANAGEMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 11      GLOBAL EPILEPSY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 12      GLOBAL ESSENTIAL TREMOR MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13      GLOBAL URINARY AND FECAL INCONTINENCE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 14      GLOBAL DEPRESSION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 15      GLOBAL DYSTONIA MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16      GLOBAL GASTROPARESIS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 17      GLOBAL PARKINSON’S DISEASE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 18      GLOBAL OTHER APPLICATIONS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19      GLOBAL NEUROSTIMULATION DEVICE MARKET BY GEOGRAPHY 2019-2027, (IN $ BILLION)

TABLE 20      CONDITION TREATED BY NEUROSTIMULATION DEVICES IN THE UNITED STATES

TABLE 21      NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 22      EUROPE NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 23      ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 24      REST OF WORLD NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

FIGURE LIST

FIGURE 1      GLOBAL NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 2      GLOBAL NEUROSTIMULATION DEVICE MARKET SHARE BY SYSTEM 2018 & 2027 (%)

FIGURE 3      GLOBAL NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)

FIGURE 4      GLOBAL NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)

FIGURE 5      GLOBAL NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE 6      GLOBAL NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL NEUROSTIMULATION DEVICE MARKET SHARE BY APPLICATIONS 2018 & 2027 (%)

FIGURE 10   GLOBAL NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL NEUROSTIMULATION DEVICE MARKET BY EPILEPSY 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCE 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL NEUROSTIMULATION DEVICE MARKET BY DYSTONIA 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE 19   PORTER’S FIVE FORCE MODEL

FIGURE 20   PREVALENCE OF MENTAL HEALTH DISORDERS ACROSS THE GLOBE BETWEEN PERIOD 2012 AND 2020 (MILLION)

FIGURE 21   RISING GERIATRIC POPULATION ACROSS THE GLOBE FOR PERIOD 2014-2020 (MILLION)

FIGURE 22   VALUE CHAIN OF NEUROSTIMULATION DRUGS

FIGURE 23   THE UNITED STATES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 24   CANADA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 25   THE UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 26   FRANCE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 27   GERMANY NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 28   SPAIN NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 29   ITALY NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 30   REST OF EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 31   INDIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 32   CHINA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 33   JAPAN NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 34   AUSTRALIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 35   SOUTH KOREA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 36   REST OF ASIA PACIFIC NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 37   LATIN AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 38   MIDDLE EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 39   NEUROSTIMULATION DEVICE COMPANY MARKET SHARE 2018 (%)

  1. MARKET BY SYSTEM
    • SPINAL CORD STIMULATORS (SCS)
    • DEEP BRAIN STIMULATORS (DBS)
    • SACRAL NERVE STIMULATORS (SNS)
    • VAGUS NERVE STIMULATORS (VNS)
    • GASTRIC ELECTRIC STIMULATOR
    • OTHER SYSTEM
  2. MARKET BY APPLICATIONS
    • PAIN MANAGEMENT
    • EPILEPSY
    • ESSENTIAL TREMOR
    • URINARY AND FECAL INCONTINENCE
    • DEPRESSION
    • DYSTONIA
    • GASTROPARESIS
    • PARKINSON’S DISEASE
    • OTHER APPLICATIONS
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now